Intracellular signaling in arterial smooth muscle migration versus proliferation

Trends in Cardiovascular Medicine

Volumn 6, Issue 5, 1996, Pages 143-151

  Bornfeldt, Karin E ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CYCLIN DEPENDENT KINASE; DNA; GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

ARTERY MUSCLE; ATHEROGENESIS; ATHEROSCLEROSIS; CALCIUM MOBILIZATION; CELL MIGRATION; DNA REPLICATION; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN METABOLISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 0030201070     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/1050-1738(96)00038-2     Document Type: Review

References (62)

1. Abedi H, Dawes KE, Zachary I: 1995. Differential effects of platelet-derived growth factor BB on p125 focal adhesion kinase and paxillin tyrosine phosphorylation and on cell migration in rabbit aortic vascular smooth muscle cells and Swiss 3T3 fibroblasts. J Biol Chem 270:11,367-11,376.
2. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR: 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270:27,489-27,494.
3. Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res. 75:1994;539-545.
4. Berridge MJ Spatial and temporal signalling by calcium. Curr Opin Cell Biol. 6:1994;267-274.
5. Bornfeldt KE, Raines EW, Nakano T, Graves LM, Krebs EG, Ross R Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J Clin Invest. 93:1994;1266-1274.
6. Bornfeldt KE, Graves LM, Raines EWet al. Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: spatial and temporal modulation of PDGF chemotactic signal transduction. J Cell Biol. 130:1995;193-206.
7. Bray D: 1992. Cell Movements. New York, Garland.
8. Brown SL, Lundgren CH, Nordt T, Fujii S Stimulation of migration of human aortic smooth muscle cells by vitronectin: implications for atherosclerosis. Cardiovasc Res. 28:1994;1815-1820.
9. Brown EJ, Beal PA, Keith CT, Chen J, Bum Shin T, Schreiber SL Control of p70 S6 kinase activity by FRAP in vivo. Nature. 377:1995;441-445.
10. 2+ stores. J Biol Chem. 268:1993;6945-6952.
11. Chang MW, Barr E, Seltzer J, et al.: 1995a. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science 267:518-522.
12. Chang MW, Barr E, Lu MM, Barton K, Leiden JM: 1995b. Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J Clin Invest 96:2260-2268.
13. Chong LD, Traynor-Kaplan A, Bokoch GM, Schwartz MA The small GTP-binding protein Rho regulates a phosphatidylinositol 4-phosphate 5-kinase in mammalian cells. Cell. 79:1994;507-513.
14. Claesson-Welsh L Signal transduction by the PDGF receptors. Prog Growth Factor Res. 5:1994;37-53.
15. Ferns GAA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science. 253:1991;1129-1132.
16. Galis ZS, Sukhova GK, Lark MW, Libby P Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 94:1994;2493-2503.
17. 3, and protein kinase C in newt eosinophils. J Cell Biol. 127:1994;489-503.
18. Graves LM, Bornfeldt KE, Argast GMet al. cAMP- and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-I in aortic smooth muscle cells. Proc Natl Acad Sci USA. 92:1995;7222-7226.
19. Grotendorst GR, Seppä HEJ, Kleinman HK, Martin GR Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor. Proc Natl Acad Sci USA. 78:1981;3669-3672.
20. Hartwig JH, Bokoch GM, Carpenter CLet al. Thrombin receptor ligation and activated Rac uncap actin filament barbed ends through phosphoinositide synthesis in permeabilized human platelets. Cell. 82:1995;643-653.
21. Hawkins PT, Eguinoa A, Qui R.G.et al. PDGF stimulates an increase in GTP-Rac via activation of phosphoinositide 3-kinase. Curr Biol. 5:1995;393-403.
22. Homma Y, Sakamoto H, Tsunoda M, Aoki M, Takenawa T, Ooyama T Evidence for involvement of phospholipase Cγ2 in signal transduction of platelet-derived growth factor in vascular smooth muscle cells. Biochem J. 290:1993;649-653.
23. Ilic D, Furuta Y, Kanazawa Set al. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature. 377:1995;539-544.
24. Indolfi C, Avvedimento EV, Rapacciuolo Aet al. Inibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nat Med. 1:1995;541-545.
25. 2+ exchanger. J Biol Chem. 270:1995;8996-9001.
26. Jefferies HBJ, Reinhard C, Kozma SC, Thomas G Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family. Proc Natl Acad Sci USA. 91:1994;4441-4445.
27. Katayose D, Wersto R, Cowan K, Seth P Consequences of p53 gene expression by adenovirus vector on cell cycle arrest and apoptosis in human aortic vascular smooth muscle cells. Biochem Biophys Res Commun. 215:1995;446-451.
28. Khalil RA, Menice CB, Wang CL, Morgan KG Phosphotyrosine-dependent targeting of mitogen-activated protein kinase in differentiated contractile vascular cells. Circ Res. 76:1995;1101-1108.
29. 2+ transients are not required for platelet-derived growth factor to induce cell cycle progression of vascular smooth muscle cells in primary culture: actions of tyrosine kinase. J Biol Chem. 269:1994;9011-9018.
30. Kundra V, Escobedo JA, Kazlauskas Aet al. Regulation of chemotaxis by the platelet-derived growth factor-β Nature. 367:1994;474-476.
31. Kundra V, Anand-Apte B, Feig LA, Zetter BR The chemotactic response to PDGF-BB: evidence of a role for Ras. J Cell Biol. 130:1995;725-731.
32. s6k function is essential for G1 progression. Nature. 363:1993;170-172.
33. 2+- and calcineurin-dependent recycling of an integrin to the front of migrating neutrophils. Nature. 377:1995;75-79.
34. Lee RT, Berditchevski F, Cheng GC, Hemler ME Integrin-mediated collagen matrix recognition by cultured human vascular smooth muscle cells. Circ Res. 76:1995;209-214.
35. Li X, Tsai P, Wieder ED, et al.: 1994. Vascular smooth muscle cells grown on Matrigel: a model of the contractile phenotype with decreased activation of mitogen-activated protein kinase. J Biol Chem 269:19,653-19,658.
36. Mahoney MG, Slakey LL, Hepler PK, Gross DJ Independent modes of propagation of calcium waves in smooth muscle cells. J Cell Sci. 104:1993;1101-1107.
37. Marx SO, Jayaraman T, Go LO, Marks AR Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res. 76:1995;412-417.
38. Matsuno H, Stassen JM, Vermylen J, Deckmyn H Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. Circulation. 90:1994;2203-2206.
39. Mitchison TJ, Cramer LP Actin-based cell motility and cell locomotion. Cell. 84:1996;371-379.
40. Mogami H, Kojima I Stimulation of calcium entry is prerequisite for DNA synthesis induced by platelet-derived growth factor in vascular smooth muscle cells. Biochem Biophys Res Commun. 196:1993;650-658.
41. Morishita R, Gibbons GH, Ellison KEet al. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J Clin Invest. 93:1994;1458-1464.
42. Nobes C, Hall A Regulation and function of the Rho subfamily of small GTPases. Curr Opin Genet Dev. 4:1994;77-81.
43. Pauly RR, Passaniti A, Bilato Cet al. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res. 75:1994;41-54.
44. Pauly RP, Bilato C, Sollott SJet al. Role of calcium/calmodulin dependent protein kinase II in the regulation of vascular smooth muscle cell migration. Circulation. 91:1995;1107-1115.
45. Qwarnström EE, Ostberg CO, Turk GL, Richardson CA, Bomsztyk K Fibronectin attachment activates the NF-kB p50/p65 heterodimer in fibroblasts and smooth muscle cells. J Biol Chem. 269:1994;30,765-30,768.
46. Raines EW, Ross R: 1993a. Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br Heart J 69:S30-S37.
47. Raines EW, Ross R: 1993b. Platelet-derived growth factor in vivo. In Westermark B, Sorg C, eds. Biology of Platelet-Derived Growth Factor, Cytokines, vol 5. Karger, Basel, pp 74-114.
48. Richardson A, Parsons JT Signal transduction through integrins: a central role for focal adhesion kinase? Bioassays. 17:1995;229-236.
49. Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell. 70:1992;401-410.
50. Rosenwald IB, Kaspar R, Rousseau D, et al.: 1995. Eukaryotic translation initiation factor 4E regulates expression of cyclin D1 at transcriptional and posttranscriptional levels. J Biol Chem 270:21,176-21,180.
51. Ross R The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
52. Seger R, Krebs EG The MAPK signaling cascade. FASEB J. 9:1995;726-735.
53. Shariff A, Luna EJ Diacylglycerol-stimulated formation of actin nucleation sites at plasma membranes. Science. 256:1992;245-247.
54. Sherr CJ G1 phase progression: cycling on cue. Cell. 79:1994;551-555.
55. 2+ pool content is linked to control of cell growth. Proc Natl Acad Sci USA. 90:1993;4986-4990.
56. Skinner MP, Raines EW, Ross R Dynamic expression of α1β1 integrin receptors by human vascular smooth muscle cells: α2β1 integrin is required for chemotaxis across type I collagen-coated membranes. Am J Pathol. 145:1994;1070-1081.
57. Stossel TP On the crawling on animal cells. Science. 260:1993;1086-1094.
58. Thyberg J, Hedin U, Sjölund M, Palmberg L, Bottger BA Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis. 10:1990;966-990.
59. Watson MH, Venance SL, Pang SC, Mak AS Smooth muscle cell proliferation: expression and kinase activities of p34cdc2 and mitogen-activated protein kinase homologues. Circ Res. 73:1993;109-117.
60. Welsh CJ, Schmeichel K, McBride K Platelet-derived growth factor activates phospholipase D and chemotactic responses in vascular smooth muscle cells. In Vitro Cell Dev Biol. 27A:1991;425-431.
61. Wennström S, Siegbahn A, Yokote Ket al. Membrane ruffling and chemotaxis transduced by the PDGF β-receptor require the binding site for phosphatidylinositol 3kinase. Oncogene. 9:1994;651-660.
62. Yanagi H, Sasaguri Y, Sugama K, Morimatsu M, Nagase H Production of tissue collagenase (matrix metalloproteinase 1) by human aortic smooth muscle cells in response to platelet-derived growth factor. Atherosclerosis. 91:1992;207-216.